136 related articles for article (PubMed ID: 25078587)
1. Relationship between RFC gene expression and intracellular drug concentration in methotrexate-resistant osteosarcoma cells.
Wang JJ; Li GJ
Genet Mol Res; 2014 Jul; 13(3):5313-21. PubMed ID: 25078587
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of methotrexate resistance in osteosarcoma cell lines and strategies for overcoming this resistance.
Wang J; Li G
Oncol Lett; 2015 Feb; 9(2):940-944. PubMed ID: 25621072
[TBL] [Abstract][Full Text] [Related]
3. The establishment and characterization of adriamycin-resistant cell lines derived from Saos-2.
Niu BH; Wang JJ; Xi Y; Ji XY
Med Sci Monit; 2010 Jun; 16(6):BR184-92. PubMed ID: 20512087
[TBL] [Abstract][Full Text] [Related]
4. Genomic imbalances associated with methotrexate resistance in human osteosarcoma cell lines detected by comparative genomic hybridization-based techniques.
Hattinger CM; Reverter-Branchat G; Remondini D; Castellani GC; Benini S; Pasello M; Manara MC; Scotlandi K; Picci P; Serra M
Eur J Cell Biol; 2003 Sep; 82(9):483-93. PubMed ID: 14582536
[TBL] [Abstract][Full Text] [Related]
5. Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells.
Serra M; Reverter-Branchat G; Maurici D; Benini S; Shen JN; Chano T; Hattinger CM; Manara MC; Pasello M; Scotlandi K; Picci P
Ann Oncol; 2004 Jan; 15(1):151-60. PubMed ID: 14679136
[TBL] [Abstract][Full Text] [Related]
6. Reversion effects of curcumin on multidrug resistance of MNNG/HOS human osteosarcoma cells in vitro and in vivo through regulation of P-glycoprotein.
Si M; Zhao J; Li X; Tian JG; Li YG; Li JM
Chin Med J (Engl); 2013 Nov; 126(21):4116-23. PubMed ID: 24229684
[TBL] [Abstract][Full Text] [Related]
7. Reduced folate carrier gene (RFC1) expression and anti-folate resistance in transfected and non-selected cell lines.
Moscow JA; Connolly T; Myers TG; Cheng CC; Paull K; Cowan KH
Int J Cancer; 1997 Jul; 72(1):184-90. PubMed ID: 9212241
[TBL] [Abstract][Full Text] [Related]
8. The folate receptor alpha is frequently overexpressed in osteosarcoma samples and plays a role in the uptake of the physiologic substrate 5-methyltetrahydrofolate.
Yang R; Kolb EA; Qin J; Chou A; Sowers R; Hoang B; Healey JH; Huvos AG; Meyers PA; Gorlick R
Clin Cancer Res; 2007 May; 13(9):2557-67. PubMed ID: 17473184
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of methotrexate resistance in osteosarcoma.
Guo W; Healey JH; Meyers PA; Ladanyi M; Huvos AG; Bertino JR; Gorlick R
Clin Cancer Res; 1999 Mar; 5(3):621-7. PubMed ID: 10100715
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of gene amplification and evidence of coamplification in drug-resistant human osteosarcoma cell lines.
Hattinger CM; Stoico G; Michelacci F; Pasello M; Scionti I; Remondini D; Castellani GC; Fanelli M; Scotlandi K; Picci P; Serra M
Genes Chromosomes Cancer; 2009 Apr; 48(4):289-309. PubMed ID: 19105235
[TBL] [Abstract][Full Text] [Related]
11. [Primary study on establishment of namalwa 12/MTX resistant cell strain and its mechanism].
Chen J; Gu LJ; Ying DM; Shen M; Wu HJ
Ai Zheng; 2002 Dec; 21(12):1335-40. PubMed ID: 12520743
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K
Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637
[TBL] [Abstract][Full Text] [Related]
13. Quantitative correlation between promoter methylation and messenger RNA levels of the reduced folate carrier.
Yang R; Li WW; Hoang BH; Kim H; Banerjee D; Kheradpour A; Healey JH; Meyers PA; Bertino JR; Gorlick R
BMC Cancer; 2008 May; 8():124. PubMed ID: 18452618
[TBL] [Abstract][Full Text] [Related]
14. Effects of melatonin combined with Cis-platinum or methotrexate on the proliferation of osteosarcoma cell line SaOS-2.
Wang YP; Yang ZP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2015 Apr; 37(2):215-20. PubMed ID: 25936711
[TBL] [Abstract][Full Text] [Related]
15. Resistance to methotrexate in SKOV-3 cell lines after chronic exposure to carbamazepine is associated with a decreased expression of folate receptor.
Toffoli G; Corona G; Tolusso B; Sartor F; Sorio R; Mini E; Boiocchi M
Int J Cancer; 2000 Mar; 85(5):683-90. PubMed ID: 10699949
[TBL] [Abstract][Full Text] [Related]
16. The overexpression of MRP4 is related to multidrug resistance in osteosarcoma cells.
He Z; Hu B; Tang L; Zheng S; Sun Y; Sheng Z; Yao Y; Lin F
J Cancer Res Ther; 2015; 11(1):18-23. PubMed ID: 25879330
[TBL] [Abstract][Full Text] [Related]
17. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
Diddens H; Niethammer D; Jackson RC
Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine phosphorylation of HSC70 and its interaction with RFC mediates methotrexate resistance in murine L1210 leukemia cells.
Liu T; Singh R; Rios Z; Bhushan A; Li M; Sheridan PP; Bearden SE; Lai JCK; Agbenowu S; Cao S; Daniels CK
Cancer Lett; 2015 Feb; 357(1):231-241. PubMed ID: 25444929
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1.
Ferrari S; Ruggieri P; Cefalo G; Tamburini A; Capanna R; Fagioli F; Comandone A; Bertulli R; Bisogno G; Palmerini E; Alberghini M; Parafioriti A; Linari A; Picci P; Bacci G
J Clin Oncol; 2012 Jun; 30(17):2112-8. PubMed ID: 22564997
[TBL] [Abstract][Full Text] [Related]
20. Influence of reduced folate carrier and dihydrofolate reductase genes on methotrexate-induced cytotoxicity.
Yoon SA; Choi JR; Kim JO; Shin JY; Zhang X; Kang JH
Cancer Res Treat; 2010 Sep; 42(3):163-71. PubMed ID: 20948922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
